Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cordasco, Edward
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection	Completed	2	63	US	TNX-102 SL, Placebo SL Tablet	Tonix Pharmaceuticals, Inc.	Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID	07/23	07/23
NCT05772520: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis	Completed	2	82	US	TLL018 tablets, TLL018 Placeboes	Hangzhou Highlightll Pharmaceutical Co., Ltd	Plaque Psoriasis	12/24	12/24
Botte, Jennifer
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection	Completed	2	63	US	TNX-102 SL, Placebo SL Tablet	Tonix Pharmaceuticals, Inc.	Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID	07/23	07/23
NCT05832151: A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis	Recruiting	2	288	US	CIN-102 Dose 15mg or 10mg, Placebo	CinDome Pharma, Inc.	Diabetic Gastroparesis	09/25	09/25